Emil Starkenstein
Emil Starkenstein (1884-1942) was a prominent pharmacologist and physiologist who made significant contributions to the field of pharmacology. He is best known for his work on the pharmacodynamics of drugs and the development of the discipline of clinical pharmacology.
Early Life and Education[edit | edit source]
Emil Starkenstein was born on 12th December 1884 in Prague, Czech Republic. He completed his early education in Prague and later pursued his medical studies at the Charles University, where he developed a keen interest in pharmacology.
Career[edit | edit source]
After completing his medical studies, Starkenstein joined the Charles University as a faculty member in the Department of Pharmacology. He dedicated his career to the study of drugs and their effects on the human body. His research focused on the pharmacodynamics of drugs, which involves the study of the biochemical and physiological effects of drugs on the body.
Starkenstein is credited with the development of the discipline of clinical pharmacology, which involves the study of drugs in humans. He was one of the first scientists to advocate for the use of controlled clinical trials in the study of drugs. His work laid the foundation for the modern practice of evidence-based medicine.
Contributions to Pharmacology[edit | edit source]
Starkenstein made several significant contributions to the field of pharmacology. He conducted extensive research on the pharmacodynamics of drugs, and his work helped to improve our understanding of how drugs interact with the body.
One of his most notable contributions was the development of the discipline of clinical pharmacology. Starkenstein recognized the importance of studying drugs in humans, and he advocated for the use of controlled clinical trials in the study of drugs. This approach has since become a cornerstone of modern medicine.
Death and Legacy[edit | edit source]
Emil Starkenstein died on 22nd March 1942. His contributions to the field of pharmacology continue to be recognized and his work has had a lasting impact on the discipline. Today, Starkenstein is remembered as one of the pioneers of clinical pharmacology.
See Also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD